Cargando…
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
Over the last 30 years, diverse types of nano-sized drug delivery systems (nanoDDSs) have been intensively explored for cancer therapy, exploiting their passive tumor targetability with an enhanced permeability and retention effect. However, their systemic administration has aroused some unavoidable...
Autores principales: | Yun, Wan Su, Kim, Jeongrae, Lim, Dong-Kwon, Kim, Dong-Hwee, Jeon, Seong Ik, Kim, Kwangmeyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421122/ https://www.ncbi.nlm.nih.gov/pubmed/37570543 http://dx.doi.org/10.3390/nano13152225 |
Ejemplares similares
-
Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
por: Kim, Jeongrae, et al.
Publicado: (2023) -
Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy
por: Kim, Jeongrae, et al.
Publicado: (2022) -
Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
por: Moon, Yujeong, et al.
Publicado: (2023) -
Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy
por: Lim, Seungho, et al.
Publicado: (2019) -
Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation
por: Cho, Hanhee, et al.
Publicado: (2022)